NCT06639711View on ClinicalTrials.gov

Taurine Eye Drops May Prevent the Progression of Cataract

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 10, 2023

Primary Completion Date

December 20, 2024

Study Completion Date

December 20, 2024

Conditions
Cataract
Interventions
DRUG

Taurine

Taurine-containing eye drops (VIZILOTON) are applied 4 times daily for a period of one year

Trial Locations (1)

31001

Al-Nahrain Eye Clinics, Ramadi

All Listed Sponsors
lead

University Of Anbar

OTHER